Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Sam Herron
ID:
1b83b8f7-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
25 articles
Eculizumab BPCIA Litigation Update: Court Denies Alexion’s Motion for an Injunction Pending Appeal
Big Molecule Watch ·
June 26, 2024
cite
Fresenius Kabi Announces Launch of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA
Big Molecule Watch ·
April 19, 2024
cite
Fresenius Kabi Announces FDA Approval of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA
Big Molecule Watch ·
March 15, 2024
cite
Regeneron’s Disputes with Celltrion, Samsung Bioepis, and Formcycon on Service and Personal Jurisdiction in Aflibercept BPCIA Litigation
Big Molecule Watch ·
January 8, 2024
cite
Celltrion Announces FDA Approval of ZYMFENTRA (infliximab-dyyb)
Big Molecule Watch ·
October 28, 2023
cite
Previous
1
2
3
4
5
Next
